Cargando…
Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy
Atorvastatin, which has been approved by regulatory agencies for primary- and secondary-prevention patients with dyslipidemia, has historically been the most commonly prescribed statin and is now widely available in generic formulations. Despite widespread statin usage, many patients fail to attain...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555050/ https://www.ncbi.nlm.nih.gov/pubmed/34586613 http://dx.doi.org/10.1007/s40119-021-00240-8 |